0001127602-18-027528.txt : 20180913
0001127602-18-027528.hdr.sgml : 20180913
20180913184132
ACCESSION NUMBER: 0001127602-18-027528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180913
FILED AS OF DATE: 20180913
DATE AS OF CHANGE: 20180913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McBride Daniel G
CENTRAL INDEX KEY: 0001368867
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08597
FILM NUMBER: 181069810
MAIL ADDRESS:
STREET 1: 5 EL CORTE
CITY: ORINDA
STATE: CA
ZIP: 94563
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COOPER COMPANIES INC
CENTRAL INDEX KEY: 0000711404
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 942657368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 6140 STONERIDGE MALL RD
STREET 2: STE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9254603600
MAIL ADDRESS:
STREET 1: 6140 STONERIDGE MALL ROAD
STREET 2: SUITE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: COOPERVISION INC
DATE OF NAME CHANGE: 19870701
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-09-13
0000711404
COOPER COMPANIES INC
COO
0001368867
McBride Daniel G
THE COOPER COMPANIES, INC.
6140 STONERIDGE MALL ROAD, SUITE 590
PLEASANTON
CA
94588
1
EVP, COO & Pres-CooperVision
Common Stock
2018-09-13
4
M
0
10310
95.74
A
38705
D
Common Stock
2018-09-13
4
S
0
4721
263.59
D
33984
D
Common Stock
2018-09-13
4
S
0
2212
264.224
D
31772
D
Common Stock
2018-09-13
4
S
0
3058
265.703
D
28714
D
Common Stock
2018-09-13
4
S
0
319
266.504
D
28395
D
Common Stock
2120
I
401(k) Plan
Employee Stock Option (Right to Buy)
95.74
2018-09-13
4
M
0
10310
0
D
2022-12-11
Common Stock
10310
0
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.00 to $263.98. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
The sales price represents a weighted average of sales prices ranging between $264.00 and $264.46.
The sales price represents a weighted average of sales prices ranging between $265.26 and $266.09.
The sales price represents a weighted average of sales prices ranging between $266.38 and $266.56.
12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.
/s/ Daniel G. McBride
2018-09-13